Gene Therapy Study Is Allowed to Resume

November 26, 2007

The Food and Drug Administration has given a Seattle company permission to resume its human tests of an experimental, gene-based arthritis treatment whose safety came into question this summer after a 36-year-old study participant died. (Washington Post)